Gardasil News
Sanofi Pasteur MSD Welcomes Sweden's Decision to Recommend and ... - PharmaLive.com (press release)
In May 2007, the Pharmaceutical Benefits Board in Sweden had included Gardasil® in the national Pharmaceutical Benefits Scheme for girls aged 13-17 years, ...
Vaccinating Boys for Girls’ Sake? - New York Times
By JAN HOFFMAN HOW cool are those Gardasil Girls? Riding horses, flinging softballs, bashing away on drum sets: on the television commercials, ...
Gardasil vaccines top 2.2 million - Sydney Morning Herald
More than 2.2 million doses of the cervical cancer vaccine Gardasil have been administered during the past year. Gardasil, which is provided free to females ...
Merck’s Gardasil vaccine encounters skepticism from some ... - Financial Times
Since Gardasil’s approval last year, there have been reports which have cited 11 deaths and adverse events which range from Guillan-Barre syndrome, ...
What's causing my repeated infections? - Jamaica Observer
It would be wise to discuss the option of receiving the vaccine GARDASIL with your doctor as this will significantly reduce your risk of developing cervical ...
CSL relaxed and comfortable as market debt jitters mean cash is ... - The Age
But the cash flow from CSL Behring is generally underwriting research and development, and the big dividend this year comes from Gardasil, the CSL-developed ...
CSL sent soaring by huge leap in profits - The Age
CSL said royalties from its Gardasil vaccine, licensed to Merck and approved in 93 countries, almost quadrupled to $81 million in the six months to December ...
CSL Profit Jumps 36% on Vaccine Sales; Shares Surge (Update7) - Bloomberg
Royalties from the Gardasil vaccine, licensed to Merck & Co., almost quadrupled in the six months ended Dec. 31, CSL said in a statement today. ...
CSL soars despite its lower forecast - The Australian
He also expected revenue from its cervical cancer vaccine Gardasil in Australia to be $80 million lower in the second half compared with the $143 million ...
Gardasil sales boost CSL profits - Melbourne Herald Sun
PHARMACEUTICAL company CSL has announced a healthy first-half profit as demand for its cervical cancer vaccine Gardasil spreads. CSL yesterday reported an ...
Gardasil RSS Feed